Christopher McGuigan insider trades: Inhibitex (INHX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christopher reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 13, 2011 | INHX | ↓ Sell | 50,000 | $14.43 | $722K | Direct | Dec 15, 2011 (2d) |
| Nov 4, 2011 | INHX | ↓ Sell | 50,000 | $9.01 | $451K | Direct | Nov 8, 2011 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Christopher McGuigan's insider trades
Christopher McGuigan is a director at Inhibitex (INHX). Since Nov 4, 2011, Christopher has reported no open-market purchases and 2 sales worth $1.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (17 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INHX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.